argenx SE (ARGX): Investment Research Report

The Gemini Brief - Investment Deep Dives · Aug 1, 2026 · 37m

Slide Deck 1. Executive Summary: The Fragility of Perfection argenx SE (ARGX) stands at a defining precipice in its corporate history. Having successfully transitioned from a clinical-stage biotechnology firm to a commercial heavyweight with a fortress balance sheet and a blockbuster asset, the company arguably represents the pinnacle of European biotech innovation over the last […]